Tag: Insulet Corp

BILLERICA, Mass. - Insulet Corp. reported revenues of $121.8 million for the third quarter of 2017, representing year-over-year growth of 28%. Net loss was 2.2 million. For the Omnipod, revenues in the U.S. were $70.1 million for the quarter, a 17% increase, and, internationally, $32.5 million, a 70% increase. Revenue from drug delivery was $19.2 million, a 19% increase. “We achieved strong third quarter results across all of our businesses, particularly in our international business,”...

BEDFORD, Mass. - Insulet Corp. has announced plans to sell Neighborhood Diabetes to Liberty Medical for $5 million. Insulet acquired Woburn, Mass.-based Neighborhood Diabetes for $63 million in 2011. "This transaction is an important step in positioning Insulet as a more focused organization, enabling us to direct our operational and financial resources toward driving continued growth of our innovative OmniPod and drug delivery products, while improving our financial profile for profitable growth...